期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 134, 期 18, 页码 7978-7982出版社
AMER CHEMICAL SOC
DOI: 10.1021/ja301710z
关键词
-
资金
- National Institutes of Health [1R01EB009565-02, U54CA119373, U54CA151652, 1DP10D006432-01]
- University of North Carolina at Chapel Hill
- Liquidia Technologies
Asymmetric bifunctional silyl ether (ABS) prodrugs of chemotherapeutics were synthesized and incorporated within 200 nm x 200 nm particles. ABS prodrugs of gemcitabine were selected as model compounds because of the difficulty to encapsulate a water-soluble drug within a hydrogel. The resulting drug delivery systems were degraded under acidic conditions and were found to release only the parent or active drug. Furthermore, changing the steric bulk of the alkyl substituents on the silicon atom could regulate the rate of drug release and, therefore, the intracellular toxicity of the gemcitabine-loaded particles. This yielded a family of novel nanoparticles that could be tuned to release drug over the course of hours, days, or months.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据